Novel therapies in breast cancer: what is new from ASCO 2008

被引：0
|
作者：
David Chu
Janice Lu
机构：
[1] State University of New York at Stony Brook,Division of Medical Oncology, Department of Medicine
来源：
Journal of Hematology & Oncology | / 1卷
关键词：
Epidermal Growth Factor Receptor; Bevacizumab; Trastuzumab; Metastatic Breast Cancer; Sunitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Novel immunologic and biologic therapies for breast cancer
    Gutheil J.C.
    Current Oncology Reports, 2000, 2 (6) : 582 - 586
  • [2] Inflammatory Breast Cancer: Novel Preoperative Therapies
    Overmoyer, Beth A.
    CLINICAL BREAST CANCER, 2010, 10 (01) : 27 - 32
  • [3] Development of new targeted therapies for breast cancer
    Danielle M. Doyle
    Kathy D. Miller
    Breast Cancer, 2008, 15 : 49 - 56
  • [4] Development of new targeted therapies for breast cancer
    Doyle, Danielle M.
    Miller, Kathy D.
    BREAST CANCER, 2008, 15 (01) : 49 - 56
  • [5] New Target Therapies for Brain Metastases from Breast Cancer
    Metro, G.
    Fabi, A.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (03) : 210 - 217
  • [6] Novel Targeted Therapies in Inflammatory Breast Cancer
    Cristofanilli, Massimo
    CANCER, 2010, 116 (11) : 2837 - 2839
  • [7] Potential of biologically targeted therapies for breast cancer
    Zielinski, Christoph
    EJC SUPPLEMENTS, 2006, 4 (13): : 23 - 26
  • [8] Integration of novel targeted therapies into the systemic treatment of breast cancer - a review
    Tsakonas, G.
    Kosmas, C.
    JOURNAL OF BUON, 2007, 12 (03): : 319 - 327
  • [9] Metastatic breast cancer - ASCO 2010
    Bartsch R.
    Ziebermayr R.
    memo - Magazine of European Medical Oncology, 2010, 3 (4) : 159 - 162
  • [10] ASCO 2007: What remains important for breast cancer systemic therapy in the routine setting?
    Harbeck, Nadia
    Rack, Brigitte
    Janni, Wolfgang
    BREAST CARE, 2007, 2 (04) : 241 - 243
12345